Filing Flows

Filing Flows › Companies › Silicon Laboratories › Cash flow

Silicon Laboratories cash flow, quarter by quarter

Latest: Q2 2026 · from the cash-flow statements filed with the SEC

Free cash flow−$26.8M in Q2 2026 · −$5.4M over twelve months

Operating cash flow−$14.5M
Capital spending−$12.3M
Free cash flow−$26.8M
Cash conversion cycle93 days

Analysis

In Q2 2026, Silicon Laboratories generated −$14.5M of operating cash flow and spent $12.3M on capital projects, leaving free cash flow of −$26.8M.

Over the twelve months to Jul 4, 2026, operating cash flow was $33.1M; the largest uses were capital spending ($38.5M), taxes on employees’ shares ($29.4M); besides operations, cash came from other investing ($67.8M), shares issued ($14.8M); the cash balance rose by $47.7M.

Operating cash flow was −$14.5M against net income of −$10.6M. The largest differences: stock-based pay +$25.6M, inventory −$20.1M, prepaid and other assets −$7.6M.

Its cash conversion cycle was 93 days (receivables 31 + inventory 118 − payables 57).

Free cash flow

Silicon Laboratories: free cash flow by quarterSilicon Laboratories: free cash flow by quarter$29.4MQ3 2024$6.2MQ4 2024$43.3MQ1 2025−$3.8MQ2 2025$27.9MQ3 2025−$1.6MQ4 2025−$4.9MQ1 2026−$26.8MQ2 2026
Operating cash flow less capital spending.
Silicon Laboratories: operating cash flow against capital spendingSilicon Laboratories: operating cash flow against capital spendingOperating cash flowCapital spending$31.6M$2.2MQ3 2024$10.1M$4.0MQ4 2024$48.1M$4.9MQ1 2025$4.9M$8.7MQ2 2025$34.3M$6.4MQ3 2025$8.3M$10.0MQ4 2025$4.9M$9.8MQ1 2026−$14.5M$12.3MQ2 2026
Latest (Q2 2026): Operating cash flow −$14.5M, Capital spending $12.3M.

Capital allocation, year by year

Silicon Laboratories: where the cash came from (up) and went (down), by fiscal yearSilicon Laboratories: where the cash came from (up) and went (down), by fiscal yearOperating cash flowNet borrowingShares issuedCapital spendingBuybacksFY2021: Operating cash flow $91.2MFY2021: Net borrowing −$141MFY2021: Shares issued $28.4MFY2021: Capital spending −$28.6MFY2021: Buybacks −$1.2B$120MFY2021FY2022: Operating cash flow $141MFY2022: Net borrowing −$21KFY2022: Shares issued $11.8MFY2022: Capital spending −$26.5MFY2022: Buybacks −$883M$153MFY2022FY2023: Operating cash flow −$30.3MFY2023: Net borrowing −$491MFY2023: Shares issued $14.6MFY2023: Capital spending −$22.3MFY2023: Buybacks −$217M$14.6MFY2023FY2024: Operating cash flow −$13.9MFY2024: Net borrowing −$45.0MFY2024: Shares issued $16.3MFY2024: Capital spending −$11.7MFY2024: Buybacks −$16K$16.3MFY2024FY2025: Operating cash flow $95.7MFY2025: Shares issued $14.6MFY2025: Capital spending −$29.9M$110MFY2025
Over these 5 years operating cash flow totalled $284M; the largest uses were buybacks ($2.3B) and net borrowing ($677M). Cash-flow statements as filed.

Cash runway and the debt wall

Cash & investments$397M
Debtnone
Net cash$397M

Silicon Laboratories's operations bring cash in ($33.1M over twelve months), and it spends more than that on capital projects: a gap of $5.4M funded from its $397M of cash and investments and from borrowing. That is a choice to invest, not a cash runway running down.

Where the cash came from and went

Silicon Laboratories: sources (+) and uses (−) of cash, Q2 2026Silicon Laboratories: sources (+) and uses (−) of cash, Q2 2026Taxes on employees’ shares−$26.5MOther investing$24.7MCash drawn (+) / kept (−)$20.9MOperating cash flow−$14.5MCapital spending−$12.3MOther financing$7.8M
Silicon Laboratories: sources (+) and uses (−) of cash, TTM to Q2 2026Silicon Laboratories: sources (+) and uses (−) of cash, TTM to Q2 2026Other investing$67.8MCash drawn (+) / kept (−)−$47.7MCapital spending−$38.5MOperating cash flow$33.1MTaxes on employees’ shares−$29.4MShares issued$14.8M

From profit to cash

Silicon Laboratories: net income to operating cash flow, Q2 2026Silicon Laboratories: net income to operating cash flow, Q2 2026Net income−$10.6MDepreciation & amortization$6.1MStock-based pay$25.6MDeferred taxes$510KReceivables−$2.7MInventory−$20.1MPayables−$1.3MPrepaid and other assets−$7.6MOther liabilities−$1.6MOperating cash flow−$14.5M
Non-cash charges are added back; money tied up in receivables or inventory is subtracted.
QuarterReceivable daysInventory daysPayable daysCash conversion cycle
Q2 2026311185793
Q1 2026301055678
Q4 2025291066471
Q3 202527856053
Q2 202526886054
Q1 2025291165986
Q4 20242814752123
Q3 20242518350157

Every quarter

QuarterOperating cash flowCapital spendingBuybacksShares issuedCash drawn (+) / kept (−)Free cash flow
Q2 2026−$14.5M−$12.3M——$20.9M−$26.8M
Q1 2026$4.9M−$9.8M——−$18.9M−$4.9M
Q4 2025$8.3M−$10.0M—$6.5M−$22.8M−$1.6M
Q3 2025$34.3M−$6.4M—$528K−$26.9M$27.9M
Q2 2025$4.9M−$8.7M—$7.6M$10.4M−$3.8M
Q1 2025$48.1M−$4.9M——−$43.3M$43.3M
Q4 2024$10.1M−$4.0M−$16K$7.0M$21.5M$6.2M
Q3 2024$31.6M−$2.2M—$1.3M−$62.2M$29.4M

Silicon Laboratories: income statement and cash flow

Silicon Laboratories, Q2 2026: revenue $228M (+18% year over year), operating margin -4.7%. The chart follows the revenue to costs, profit and cash.

Silicon Laboratories: every quarter, Q/Q and Y/Y → Open in the app

Read automatically from the company’s XBRL cash-flow statements; quarterly figures for the fourth quarter are the year less the first three. Errors are possible. Not investment advice.